Related Experiment Video
Updated: Aug 23, 2026

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
Published on: April 17, 2026
Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2
Min Liang1, Yao-Yun Liang, Katharine Wrighton
1Department of Molecular & Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Room 137D, Houston, TX 77030, USA.
Abstract:
Smad4/DPC4, a common signal transducer in transforming growth factor beta (TGF-beta) signaling, is frequently inactivated in human cancer. Although the ubiquitin-proteasome pathway has been established as one mechanism of inactivating Smad4 in cancer, the specific ubiquitin E3 ligase for ubiquitination-mediated proteolysis of Smad4 cancer mutants remains unclear. In this report, we identified the SCFSkp2 complex as candidate Smad4-interacting proteins in an antibody array-based screen and further elucidated the functions of SCFSkp2 in mediating the metabolic instability of cancer-derived Smad4 mutants. We found that Skp2, the F-box component of SCFSkp2, physically interacted with Smad4 at the physiological levels. Several cancer-derived unstable mutants exhibited significantly increased binding to Skp2, which led to their increased ubiquitination and accelerated proteolysis. These results suggest an important role for the SCFSkp2 complex in switching cancer mutants of Smad4 to undergo polyubiquitination-dependent degradation.
Insights
The SCFSkp2 complex targets cancer-associated Smad4 mutants for degradation. This identifies a key mechanism in Smad4 protein instability and cancer progression, involving Skp2-mediated ubiquitination.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- Smad4 (also known as DPC4) is a crucial signal transducer in transforming growth factor beta (TGF-beta) signaling pathways.
- Inactivation of Smad4 is a common event in human cancers.
- The ubiquitin-proteasome system plays a role in Smad4 inactivation, but the specific E3 ligase involved in targeting cancer mutants remains unidentified.
Purpose of the Study:
- To identify the specific ubiquitin E3 ligase responsible for the ubiquitination-mediated proteolysis of cancer-derived Smad4 mutants.
- To elucidate the role of the SCFSkp2 complex in the metabolic instability of Smad4 cancer mutants.
Main Methods:
- Antibody array-based screening to identify Smad4-interacting proteins.
- Co-immunoprecipitation assays to confirm physical interaction between Skp2 and Smad4.
- Analysis of ubiquitination and proteolysis of Smad4 mutants in the presence of SCFSkp2.
Main Results:
- The SCFSkp2 complex was identified as a candidate Smad4-interacting protein complex.
- Skp2, the F-box protein of SCFSkp2, physically interacts with Smad4.
- Cancer-derived Smad4 mutants showed enhanced binding to Skp2, leading to increased ubiquitination and accelerated proteasomal degradation.
Conclusions:
- The SCFSkp2 complex plays a significant role in the metabolic instability of cancer-derived Smad4 mutants.
- Skp2 mediates the polyubiquitination and subsequent degradation of Smad4 mutants, suggesting a novel mechanism for Smad4 inactivation in cancer.
Related Concept Videos
Anaphase Promoting Complex
TGF - β Signaling Pathway
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

